Cannabis Law Report

JULY 23, 2019

(TSXV: LG and OTC-QB: LGGCF) (“ LGC ”) is pleased to announce that it has paid the 2 nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). This EU pharmaceutical entity is an optimal addition to LGC. Tel: (416) 644-2020 or (514) 939-3989.

Pharmaceutical 45

Pharmaceutical Seed-To-Sale Compliance Compliance 45

Cannabis Law Report

JUNE 28, 2021

PUTRAJAYA: The courts cannot sidestep any government policy on cannabis unless it is against the law, a Federal Court bench said. Muhammad Lukman Mohamad, who is said to have sold cannabis oil to treat cancer patients, escaped the gallows on two counts of trafficking.

Policy 75

Policy Law Oil Cannabinoids 75

SpeedWeed

MARCH 13, 2021

Almost 25% of patients with Parkinson’s disease reported that they had used cannabis in the prior six months in a survey from the Parkinson’s Foundation. Parkinson’s disease patients typically use pharmaceutical medications to treat their condition with varying degrees of success. More Than 1,000 PD Patients Surveyed.

Patients 52

Patients Treatment Therapy Sleep 52

Cannabis Law Report

JULY 21, 2022

COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that it has appointed Kabir Nath as Chief Executive Officer, effective August 1, 2022. London, UK July 19, 2022.

Therapy 52

Therapy Research and Development Pharmaceutical Patients 52

Veriheal

JUNE 19, 2023

The prominent players, as explained by the psychedelic market report, include Pfizer, Verrian, GlaxoSmithKline, COMPASS Pathways PLC, MindMed, Janssen Pharmaceuticals PLC, HAVN Life Sciences, Seelos Therapeutics, Field Trip Health, amongst others. LSD can be used to deal with anxiety due to stress as well as depression.

Therapy 105

Therapy Treatment Patients Policy 105

NORML

NOVEMBER 8, 2019

Prohibiting VA doctors from recommending cannabis to qualifying patients, while continuing to rely on pharmaceuticals drugs like opioids as a treatment, is both a dangerous and illogical policy.

Access 212

Access Marijuana Treatment Legislation 212

The Cannigma

JUNE 14, 2021

All that is about to change, thanks to a change at the DEA , which cultivators and industry experts say will be monumental for cannabis research, medical marijuana patients, and potentially the broader legal status of the plant itself. “We Unfortunately, this change in policy has been promised for years and never actually materialized.”.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

NORML

FEBRUARY 23, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. It would not allow patients to smoke herbal marijuana or vape, but would allow forms including pills, oils, lozenges and patches. AL resident?

Legislation 241

Legislation Patients Decriminalization Access 241

United Patients Group

FEBRUARY 7, 2023

Cannabis is an effective treatment for pain and inflammation Cannabis is a natural alternative to pharmaceutical drugs. The most effective way depends on the patient’s condition and overall health status but generally speaking most people prefer inhalation over other methods because it delivers relief quickly (within minutes).

Cannabinoids 114

Cannabinoids Chronic Pain Terpenes THC 114

Project CBD

MARCH 8, 2019

Immediately in response, the FDA announced that CBD is considered a “drug” and is thus subject to pharmaceutical regulations. As of February 2019, the Veterinary Medical Board in California still has no official policy on hemp products. Medical Cannabis in California.

Pets 215

Pets Legalization Hemp Extraction 215

MMJ Recs

JUNE 26, 2020

The Sooner State has more dispensaries than any other state, as well as more MMJ patients per capita. When OK legalized MMJ in 2018, it began providing licenses to businesses and MMJ cards to patients almost right away. A lot was left up to the discretion of the MMJ industry, employers, medical professionals, and patients.

Marijuana 69

Marijuana Safety Pharmaceutical Patients 69

The Cannigma

JUNE 1, 2021

Marijuana is not legal in France, and the country is seen as having some of the strictest cannabis policies in western Europe. Under the plan, some 3,000 patients in France will be treated with medical cannabis and monitored closely. Such patients can only receive a 30 day supply and must renew the prescription every six months.

Law 113

Law Epilepsy Programs Patients 113

MMJ Recs

MARCH 23, 2024

Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief. It prompts considerations regarding patient access, treatment options, and healthcare provider involvement.

Legalization 52

Legalization Access Programs Education 52

MJ Business Attorneys

JUNE 29, 2018

Epidiolex is the first drug the FDA has approved that contains a substance derived from marijuana, and it is also the first drug approved by the FDA to be used to treat patients with Dravet syndrome. CBD will increasingly become even more heavily regulated on both the state and federal levels.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

NORML

JANUARY 11, 2019

Legislation is pending, Senate Bill 2134, to permit qualifying patients to cultivate personal use quantities of cannabis for therapeutic purposes. The measure would permit patients to grow up to nine cannabis plants in a locked, enclosed facility, and to possess up to three ounces of home-grown medical cannabis. NH resident?

Legislation 198

Legislation Decriminalization Hemp Patients 198

Cannabis Law Report

APRIL 21, 2022

Commercialization & Patient Access · Any City, Any State, California. We are a new kind of pharmaceutical company that prioritizes public benefit over profit and is committed to sustainability, accountability, and transparency. The State Government Affairs Lead will oversee MAPS PBC’s policy efforts at the state level.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

Cannabis Law Report

NOVEMBER 23, 2019

for the production R&D of pharmaceutical grade standardised cannabis. Here the company shares their evolution with Health Europa, exploring the production of pharmaceutical grade standardised cannabis. KANNABEIRA® is a project and a registered trademark under the company Green Donation, Ltd. KANNABEIRA and standardised cannabis.

Pharmaceutical 45

Pharmaceutical Research and Development Cultivation Environment 45

United Patients Group

FEBRUARY 2, 2023

The cannabinoids found within cannabis have been shown to help boost our natural defenses against illness by improving our overall health status rather than just treating symptoms like most pharmaceuticals do (i.e., The post Using Cannabis For Health and Wellness appeared first on United Patients Group. antibiotics).

Blood Pressure 103

Blood Pressure Sleep Chronic Pain Digestion 103

Cannabis Law Report

MARCH 29, 2022

Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. Prior to his work at Moderna, Mullette developed broad pharmaceutical expertise with Sanofi in a variety of management roles in the U.S., Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. He holds a B.S.

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

The Cannigma

MARCH 25, 2021

Executive Director of the Criminal Justice Policy Foundation told The Cannigma during a Zoom call this week. “A Sterling mentioned fears that officials may have about cannabis making its way out into the general population of the prison, though he added that’s a concern with any pharmaceutical provided by prison health services.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

Veriheal

DECEMBER 24, 2021

One of the original authors of the Compassionate Use of Medical Cannabis Pilot Program Act in 2013 (MCPP) — a law that led to the legalization of pharmaceutical-grade cannabis across the state of Illinois — says that growing demand and acceptance of the federally illegal plant has not reduced the risk of job loss.

Legislation 90

Legislation Recreational Patients Cannabis 90

The Cannigma

NOVEMBER 2, 2021

Overall, 65% of the respondents said that they use cannabis in lieu of prescription pharmaceuticals. The survey was compiled by Amanda Reiman , PhD MSW, the California policy manager for the Drug Policy Alliance. In addition, they were also significantly more likely to report more use days per week.

Cannabis 134

Cannabis Policy Pharmaceutical Patients 134

NORML

FEBRUARY 29, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. The Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act (HR 3884 / S. HI resident? New Hampshire. West Virginia.

Legislation 147

Legislation Decriminalization Patients Edibles 147

Cannabis Law Report

JANUARY 16, 2020

The European Medicinal Cannabis Association (EUMCA), the newly formed Brussels-based industry body which advocates for European evidence-based policy to improve patient access to high-quality cannabis treatment, has announced the appointment of Professor Jones, CBE, FMedSci, as its new Chairman. Professor Jones.

Medicine 59

Medicine Research and Development Pharmaceutical Policy 59

Cannabis Law Report

OCTOBER 10, 2021

As a think tank we develop new ideas and concepts for providing medical cannabis to patients both in Germany and Europe. Cantourage is an innovative company ensuring that patients are able to access the newest medicinal products based on cannabis. “Development by innovation” is not an empty promise but our daily work motivator.

Clinical Trials 52

Clinical Trials Therapy Medicine Policy 52

MedicalJane

MAY 14, 2020

It continues to enforce restrictive policies and regulations on research into the health benefits or harms of cannabis products that are available to consumers across the nation. Because of this, some cannabis companies are even investing money into facilitating their own private studies to get a better understanding of what patients need.

Sleep 95

Sleep Edibles DEA Policy 95

NORML

FEBRUARY 1, 2019

At the state level, activists in Florida and Missouri gathered in their state capitals along side state and local NORML chapters to lobby state lawmakers in favor of sensible marijuana policy reform. The measure would permit medical cannabis patients to grow up to six cannabis plants. John Fetterman, Lt. CT resident? Update : S.

Legislation 164

Legislation Decriminalization Access Patients 164

Cannabis Law Report

SEPTEMBER 1, 2021

Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. Thorough knowledge of EU regulations as well as ability to interpret policies and guidelines. Employer questions.

Research and Development 105

Research and Development Supply Chain Compliance Compliance 105

Cannabis Law Report

JULY 30, 2019

Following an encouraging initial US launch, GW Pharmaceuticals’s cannabidiol oral solution is also set to achieve European approval later in 2019. Knowledge, attitudes and policies regarding medical cannabis and cannabis-based drugs are changing. Here are the takeaways ( Source Fitch).

Epilepsy 40

Epilepsy Pharmaceutical Medicine Treatment 40

Veriheal

JUNE 20, 2022

.” The LPP’s mission is: “Through intervention, advocacy, and awareness campaigns the Last Prisoner Project works to redress the past and continuing harms of these unjust laws and policies.” The FDA has also approved a few cannabis-based pharmaceutical drugs. According to the U.S.

Chronic Pain 82

Chronic Pain Advocacy Pharmaceutical Legalization 82

Veriheal

OCTOBER 29, 2020

Is the focus on the negative impact due to the fact that role players want cannabis to remain illicit as to avoid its potential role in replacing pharmaceutical medication? Scenario 2: Pharmaceuticals. However, the focus of funding remains on negative impacts. How could we move the focus towards understanding the benefits?

Pharmaceutical 98

Pharmaceutical Therapy Cannabinoids Chronic Pain 98

Cannabis Law Report

APRIL 1, 2022

CELADON Pharmaceuticals successfully listed on the Alternative Investments Market (AIM) this week, making it the first British company to join in 21 years. Business Cann. Admission . The newly formed entity now has 61.7m ordinary shares in issue, giving it a market capitalisation at admission of £97.4 million at a share price of 158p.

Chronic Pain 52

Chronic Pain Pharmaceutical Sativa Business 52

Cannabis Law Report

JANUARY 10, 2020

Schlag has a keen interest in national and international drug policies, related regulatory challenges and public communications. CEO of Anspec and MD of Australia and Asia-Pacific for The Flowr Corporation, expert pharmaceutical supply and complex logistics, hi-tech manufacturing, consulting, public and private healthcare.

Research and Development 59

Research and Development Supply Chain Pharmaceutical Medicine 59

Cannabis Law Report

JUNE 26, 2019

First and foremost, I’ll highlight the patient perspective, patients like myself who are legally registered State of Florida Medical Marijuana active ID cardholders. I am a medical patient in Florida’s Medical Marijuana Use Registry due my qualifying condition: a 2010 diagnosis of aggressive Multiple Sclerosis.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

Canna Law Blog

FEBRUARY 19, 2020

The second track for psilocybin is the pharmaceutical model. The closest we may get to “legalization” will be in proposals such as Oregon’s Measure 34, which goes beyond mere decriminalization to create a state-sanctioned “patient and caregiver” framework. At some point, federal policy finally evolves and change becomes inevitable.

Decriminalization 110

Decriminalization Research and Development Therapy Pharmaceutical 110

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. billion by 2027.

Therapy 76

Therapy Data Research and Development Events 76

Cannabis Law Report

JUNE 14, 2019

Agriculture Commissioner Nikki Fried announced Monday a new Medical Marijuana Advisory Committee, which she says will collaborate with the Florida Department of Agriculture and Consumer Services to help improve the state’s medical marijuana policies. Here are the details care of Sunshine State News.

Agriculture 40

Agriculture Marijuana Research and Development Policy 40